Cormorant Asset Management

Cormorant Asset Management as of March 31, 2019

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 64 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Inflarx Nv (IFRX) 6.6 $98M 2.6M 37.79
SPDR S&P Biotech (XBI) 5.7 $84M 925k 90.54
Mirati Therapeutics (MRTX) 5.3 $79M 1.1M 73.30
Ascendis Pharma A S (ASND) 4.8 $71M 600k 117.70
Apellis Pharmaceuticals (APLS) 4.7 $70M 3.6M 19.50
Anaptysbio Inc Common (ANAB) 4.5 $67M 920k 73.05
Biohaven Pharmaceutical Holding 3.8 $57M 1.1M 51.47
Reata Pharmaceuticals Inc Cl A 3.5 $53M 615k 85.47
Principia Biopharma 3.2 $48M 1.4M 34.00
Quotient 2.8 $41M 4.6M 9.01
Tricida 2.6 $39M 1.0M 38.62
Blueprint Medicines (BPMC) 2.4 $36M 450k 80.05
Sarepta Therapeutics (SRPT) 2.4 $36M 300k 119.19
Chemocentryx 2.4 $35M 2.5M 13.89
Galapagos Nv- (GLPG) 2.4 $35M 300k 116.55
Argenx Se (ARGX) 2.3 $34M 275k 124.84
Crispr Therapeutics (CRSP) 2.2 $32M 900k 35.72
Myokardia 2.1 $31M 600k 51.99
Axonics Modulation Technolog (AXNX) 2.1 $31M 1.3M 23.95
Allakos (ALLK) 2.0 $30M 750k 40.50
Rocket Pharmaceuticals (RCKT) 2.0 $30M 1.7M 17.54
Autolus Therapeutics Plc spon ads (AUTL) 1.8 $27M 850k 31.47
Zogenix 1.7 $25M 450k 55.01
Kura Oncology (KURA) 1.6 $23M 1.4M 16.59
Kezar Life Sciences (KZR) 1.6 $23M 1.3M 17.74
Atara Biotherapeutics (ATRA) 1.5 $22M 550k 39.75
Sage Therapeutics (SAGE) 1.4 $21M 130k 159.05
Y Mabs Therapeutics (YMAB) 1.3 $19M 716k 26.21
Constellation Pharmceticls I 1.2 $17M 1.3M 13.55
Nektar Therapeutics (NKTR) 1.1 $17M 500k 33.60
Twist Bioscience Corp (TWST) 1.1 $16M 706k 23.18
Myovant Sciences 1.1 $16M 650k 23.87
Inspire Med Sys (INSP) 1.0 $14M 250k 56.78
Gossamer Bio (GOSS) 1.0 $14M 653k 21.67
Precision Biosciences Ord (DTIL) 0.9 $14M 780k 17.95
Amarin Corporation (AMRN) 0.8 $13M 600k 20.76
Array BioPharma 0.8 $12M 500k 24.38
Eidos Therapeutics 0.8 $12M 508k 23.45
Rubius Therapeutics 0.8 $12M 650k 18.10
Orchard Therapeutics Plc ads 0.8 $12M 650k 17.89
Arena Pharmaceuticals 0.8 $11M 250k 44.83
Zai Lab (ZLAB) 0.7 $10M 350k 29.51
Ra Pharmaceuticals 0.6 $9.0M 400k 22.40
Genfit S A ads (GNFT) 0.6 $8.4M 350k 24.00
Neurocrine Biosciences (NBIX) 0.5 $7.9M 90k 88.10
Phasebio Pharmaceuticals (PHASQ) 0.5 $8.0M 840k 9.51
Avrobio Ord (AVRO) 0.5 $6.6M 300k 22.05
Harpoon Therapeutics 0.4 $6.4M 674k 9.47
Kiniksa Pharmaceuticals (KNSA) 0.3 $4.9M 270k 18.06
Minerva Neurosciences 0.3 $4.8M 608k 7.86
Translate Bio 0.3 $4.6M 455k 10.19
X4 Pharmaceuticals (XFOR) 0.3 $4.4M 253k 17.41
Audentes Therapeutics 0.3 $3.9M 100k 39.02
Heron Therapeutics (HRTX) 0.2 $3.7M 150k 24.44
Scholar Rock Hldg Corp (SRRK) 0.2 $3.4M 179k 18.79
Iterum Therapeutics 0.2 $3.2M 398k 8.03
Abeona Therapeutics 0.2 $2.9M 400k 7.36
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.2 $3.0M 200k 15.14
Incyte Corporation (INCY) 0.2 $2.6M 30k 86.00
Aclaris Therapeutics (ACRS) 0.2 $2.5M 421k 5.99
Solid Biosciences 0.2 $2.3M 250k 9.20
Acceleron Pharma 0.1 $1.9M 40k 46.58
Outlook Therapeutics Inc *w exp 02/18/201 0.0 $150k 417k 0.36
Cellectar Biosciences Equity Warrants *w 0.0 $4.8k 53k 0.09